NO2324360T3 - - Google Patents
Info
- Publication number
- NO2324360T3 NO2324360T3 NO09807153A NO09807153A NO2324360T3 NO 2324360 T3 NO2324360 T3 NO 2324360T3 NO 09807153 A NO09807153 A NO 09807153A NO 09807153 A NO09807153 A NO 09807153A NO 2324360 T3 NO2324360 T3 NO 2324360T3
- Authority
- NO
- Norway
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
- A61B5/4064—Evaluating the brain
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Psychology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18855408P | 2008-08-11 | 2008-08-11 | |
US9762208P | 2008-09-17 | 2008-09-17 | |
US21872709P | 2009-06-19 | 2009-06-19 | |
PCT/US2009/053376 WO2010019553A2 (fr) | 2008-08-11 | 2009-08-11 | Procédé de détection de biomarqueurs et test d'état neurologique |
Publications (1)
Publication Number | Publication Date |
---|---|
NO2324360T3 true NO2324360T3 (fr) | 2018-06-30 |
Family
ID=41669607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO09807153A NO2324360T3 (fr) | 2008-08-11 | 2009-08-11 |
Country Status (9)
Country | Link |
---|---|
US (3) | US20110143375A1 (fr) |
EP (3) | EP4235181A3 (fr) |
JP (2) | JP5781436B2 (fr) |
AU (1) | AU2009282117B2 (fr) |
CA (1) | CA2733990C (fr) |
DK (1) | DK2324360T3 (fr) |
ES (1) | ES2665245T3 (fr) |
NO (1) | NO2324360T3 (fr) |
WO (1) | WO2010019553A2 (fr) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1519194A1 (fr) | 2003-09-24 | 2005-03-30 | Roche Diagnostics GmbH | L'utilisation de GFAP pour identifier une hémorragie intracérébrale |
US8492107B2 (en) | 2004-04-15 | 2013-07-23 | University Of Florida Research Foundation, Inc. | Neural proteins as biomarkers for nervous system injury and other neural disorders |
SG10201704689XA (en) | 2008-01-18 | 2017-07-28 | Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
EP4235181A3 (fr) * | 2008-08-11 | 2024-02-28 | Banyan Biomarkers Inc | Procédé de détection de biomarqueur et dosage d'état neurologique |
EP3355059A3 (fr) * | 2009-06-19 | 2018-09-26 | Banyan Biomarkers, Inc. | Analyse de biomarqueur de maladie neurologique |
WO2011011334A2 (fr) * | 2009-07-18 | 2011-01-27 | Banyan Biomarkers, Inc. | Dosage par biomarqueur synergique d'état neurologique à l'aide de s-100β |
JP5909447B2 (ja) * | 2009-09-14 | 2016-04-26 | バンヤン・バイオマーカーズ・インコーポレーテッド | ニューロン損傷診断のためのマイクロrna、自己抗体およびタンパク質マーカー |
EP2531224B1 (fr) | 2010-01-26 | 2019-06-05 | Bioregency, Inc. | Compositions et procédés associés à l'argininosuccinate synthétase |
AU2011235892B2 (en) * | 2010-04-01 | 2016-07-07 | Banyan Biomarkers, Inc. | Markers and assays for detection of neurotoxicity |
WO2011160096A2 (fr) * | 2010-06-17 | 2011-12-22 | Banyan Biomarkers, Inc. | Protéine acide fibrillaire gliale, auto-antigènes et auto-anticorps contre ceux-ci en tant que biomarqueurs de lésion neurale ou de trouble ou affection neurologique |
MX361944B (es) | 2010-07-23 | 2018-12-19 | President And Fellows Of Harvard College Star | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales. |
US20130203624A1 (en) | 2010-07-23 | 2013-08-08 | President And Fellows Of Harvard College | Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions |
AU2011280997A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
JP2013541323A (ja) | 2010-07-23 | 2013-11-14 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | 貪食細胞を用いて疾患または症状のシグネチャを検出する方法 |
WO2012051519A2 (fr) * | 2010-10-14 | 2012-04-19 | The Johns Hopkins University | Biomarqueurs d'une lésion cérébrale |
WO2012142301A2 (fr) | 2011-04-12 | 2012-10-18 | Quanterix Corporation | Procédé de détermination d'un protocole de traitement et/ou d'un pronostic de rétablissement d'un patient à la suite d'un traumatisme cérébral |
JP2014518624A (ja) | 2011-05-12 | 2014-08-07 | ザ・ジョンズ・ホプキンス・ユニバーシティー | ニューログラニン診断キットのためのアッセイ試薬 |
WO2013090285A1 (fr) * | 2011-12-14 | 2013-06-20 | University Of Rochester | Méthode de diagnostic de lésion cérébrale traumatique légère |
WO2013138509A1 (fr) | 2012-03-13 | 2013-09-19 | The Johns Hopkins University | Protéines cérébrales et neurologiques citrullinées en tant que biomarqueurs de lésions cérébrales ou de neurodégénérescence |
KR20150035821A (ko) | 2012-06-15 | 2015-04-07 | 해리 스타일리 | 질환 또는 병태를 검출하는 방법 |
KR20150035818A (ko) | 2012-06-15 | 2015-04-07 | 해리 스타일리 | 순환 병든 세포를 사용하여 질환 또는 병태를 검출하는 방법 |
US11585814B2 (en) | 2013-03-09 | 2023-02-21 | Immunis.Ai, Inc. | Methods of detecting prostate cancer |
US10494675B2 (en) | 2013-03-09 | 2019-12-03 | Cell Mdx, Llc | Methods of detecting cancer |
WO2014144133A1 (fr) * | 2013-03-15 | 2014-09-18 | The Trustees Of The Princeton University | Perfectionnement apporté à la détection d'analytes par immobilisation ciblée, amplification de surface et lecture et analyse pixelisées |
US20150141528A1 (en) * | 2013-05-31 | 2015-05-21 | Banyan Biomarkers, Inc. | Neural specific s100b for biomarker assays and devices for detection of a neurological condition |
US10534003B2 (en) * | 2013-07-17 | 2020-01-14 | The Johns Hopkins University | Multi-protein biomarker assay for brain injury detection and outcome |
CN106605146B (zh) * | 2014-04-08 | 2020-07-28 | 佛罗里达大学研究基金会有限公司 | 用于中枢神经系统的急性、亚急性和慢性创伤性损伤的蛋白质标志物 |
WO2016040843A1 (fr) | 2014-09-11 | 2016-03-17 | Harry Stylli | Procédés pour détecter le cancer de la prostate |
WO2016055148A2 (fr) * | 2014-10-06 | 2016-04-14 | Université De Genève | Marqueurs et leur utilisation en lien avec une lésion cérébrale |
US20190010504A1 (en) * | 2015-12-11 | 2019-01-10 | Arizona Board Of Regents On Behalf Of Arizona State University | Human alzheimer's disease and traumatic brain injury associated tau variants as biomarkers and methods of use thereof |
BR112019006710A2 (pt) * | 2016-10-03 | 2019-06-25 | Abbott Lab | métodos aprimorados para avaliação do estado da uch-l1 em amostras de pacientes |
EP3532496A1 (fr) | 2016-10-28 | 2019-09-04 | Banyan Biomarkers, Inc. | Anticorps dirigés contre l'ubiquitine c-terminale hydrolase l1 (uch-l1) et la protéine acide fibrillaire gliale (gfap) et méthodes associées |
US10345302B2 (en) * | 2017-02-19 | 2019-07-09 | Sheng-He Huang | Circulating astrocytes and MFSD2A as biomarkers |
US11016092B2 (en) | 2017-03-23 | 2021-05-25 | Abbott Laboratories | Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase L1 |
EP3602069A1 (fr) * | 2017-03-23 | 2020-02-05 | Abbott Laboratories | Méthodes d'aide au diagnostic et à la détermination de l'étendue d'une lésion cérébrale traumatique chez un sujet humain à l'aide du biomarqueur précoce hydrolase carboxy-terminale d'ubiquitine l1 |
WO2018191531A1 (fr) | 2017-04-15 | 2018-10-18 | Abbott Laboratories | Procédés d'aide au diagnostic hyperaigu et de détermination d'une lésion cérébrale traumatique chez un sujet humain à l'aide de biomarqueurs précoces |
BR112019022476A2 (pt) | 2017-04-28 | 2020-05-12 | Abbott Laboratories | Métodos para o auxílio no diagnóstico e determinação hiperagudos de lesão cerebral traumática usando biomarcadores iniciais em pelo menos duas amostras a partir do mesmo ser humano |
CA3078725A1 (fr) * | 2017-05-25 | 2018-11-29 | Abbott Laboratories | Procedes d'aide a la determination de la realisation ou non d'une imagerie sur un sujet humain ayant subi ou susceptible d'avoir subi une lesion a la tete a l'aide de biomarqueurs precoces |
BR112019025313A2 (pt) * | 2017-05-30 | 2020-06-23 | Abbott Laboratories | Métodos para auxílio no diagnóstico e avaliação de uma lesão cerebral traumática leve em um indivíduo humano usando troponina cardíaca i |
EP3649474A1 (fr) | 2017-07-03 | 2020-05-13 | Abbott Laboratories | Procédés améliorés de mesure de niveaux d'hydrolase à terminaison carboxy d'ubiquitine l1 dans le sang |
WO2019018545A1 (fr) | 2017-07-18 | 2019-01-24 | The Research Foundation For The State University Of New York | Biomarqueurs d'anévrisme intracrânien |
US11016105B2 (en) | 2017-12-09 | 2021-05-25 | Abbott Laboratories | Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1 |
EP3721233A2 (fr) * | 2017-12-09 | 2020-10-14 | Abbott Laboratories | Procédés d'aide au diagnostic et à l'évaluation d'un sujet qui a subi une lésion orthopédique et qui a subi ou peut avoir subi une lésion à la tête, telle qu'une lésion cérébrale traumatique légère (tbi), à l'aide d'une protéine acide fibrillaire gliale (gfap) et/ou d'hydrolase carboxy-terminale d'ubiquitine l1 (uch-l1) |
WO2019199871A1 (fr) * | 2018-04-10 | 2019-10-17 | Quanterix Corporation | Quantification de chaînes légères de neurofilament dans des échantillons physiologiques |
KR102179032B1 (ko) * | 2019-09-20 | 2020-11-18 | 한림대학교 산학협력단 | 급성허혈성뇌손상 및 급성외상성뇌손상을 구별하기 위한 바이오마커 및 이의 이용 |
JP2023551542A (ja) | 2020-11-30 | 2023-12-08 | エニグマ バイオインテリジェンス,インコーポレイテッド | アルツハイマー病の非侵襲的評価 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5234814A (en) * | 1989-06-01 | 1993-08-10 | Du Pont Merck Pharmaceutical Company | Diagnostic assay for alzheimer's disease |
US5660985A (en) | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
US5567588A (en) | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
US5496938A (en) | 1990-06-11 | 1996-03-05 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to HIV-RT and HIV-1 rev |
US5707796A (en) * | 1990-06-11 | 1998-01-13 | Nexstar Pharmaceuticals, Inc. | Method for selecting nucleic acids on the basis of structure |
US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
ES2259800T3 (es) | 1990-06-11 | 2006-10-16 | Gilead Sciences, Inc. | Procedimientos de uso de ligandos de acido nucleico. |
US6011020A (en) | 1990-06-11 | 2000-01-04 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
US5637459A (en) | 1990-06-11 | 1997-06-10 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chimeric selex |
US5683867A (en) | 1990-06-11 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: blended SELEX |
US5252463A (en) * | 1990-06-22 | 1993-10-12 | The Du Pont Merck Pharmaceutical Company | Clipsin, a chymotrypsin-like protease and method of using same |
US5536639A (en) * | 1994-03-25 | 1996-07-16 | Cephalon, Inc. | Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products |
ATE268816T1 (de) * | 1994-07-15 | 2004-06-15 | Cephalon Inc | In baculovirus exprimiertes aktives calpain |
US5614649A (en) * | 1994-11-14 | 1997-03-25 | Cephalon, Inc. | Multicatalytic protease inhibitors |
US5777194A (en) * | 1995-04-26 | 1998-07-07 | Cephalon, Inc. | Gene-targeted mice with humanized Aβ sequence and Swedish FAD mutation |
US6048703A (en) * | 1996-11-15 | 2000-04-11 | Cephalon, Inc. | Methods for detecting cell apoptosis |
US6218005B1 (en) * | 1999-04-01 | 2001-04-17 | 3M Innovative Properties Company | Tapes for heat sealing substrates |
US6664442B2 (en) * | 2000-03-30 | 2003-12-16 | Elan Pharmaceuticals, Inc. | Selecting compounds to reduce inflammation associated with Alzheimer's disease |
WO2003016910A1 (fr) * | 2001-08-20 | 2003-02-27 | Biosite, Inc. | Marqueurs diagnostiques d'ictus et de lesions cerebrales et procedes d'utilisation de ces marqueurs |
AU2002329570A1 (en) * | 2001-10-12 | 2003-01-30 | Pfizer Products Inc. | Method of monitoring neuroprotective treatment |
WO2004025298A1 (fr) * | 2002-09-11 | 2004-03-25 | University Of Florida | Procedes d'analyse de lesions de cellules nerveuses |
EP2357477B1 (fr) | 2003-09-20 | 2017-11-08 | Electrophoretics Limited | Méthode de diagnostic de troubles associés à des lésions cérébrales basée sur la détection de NDKA |
GB0322063D0 (en) * | 2003-09-20 | 2003-10-22 | Univ Geneve | Diagnostic method for brain damage-related disorders |
EP1519194A1 (fr) * | 2003-09-24 | 2005-03-30 | Roche Diagnostics GmbH | L'utilisation de GFAP pour identifier une hémorragie intracérébrale |
EP2207033B1 (fr) * | 2004-04-15 | 2014-06-18 | University of Florida Research Foundation, Inc. | Protéines neuronales en tant que biomarqueurs pour blessure traumatique du système nerveux et autres troubles neuronaux |
ES2367311T3 (es) * | 2004-04-15 | 2011-11-02 | University Of Florida Research Foundation, Inc. | Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales. |
EP3115785A3 (fr) | 2008-02-04 | 2017-02-22 | Banyan Biomarkers, Inc. | Procédé pour diagnostiquer ou traiter des lésions cérébrales |
EP4235181A3 (fr) * | 2008-08-11 | 2024-02-28 | Banyan Biomarkers Inc | Procédé de détection de biomarqueur et dosage d'état neurologique |
WO2018191531A1 (fr) * | 2017-04-15 | 2018-10-18 | Abbott Laboratories | Procédés d'aide au diagnostic hyperaigu et de détermination d'une lésion cérébrale traumatique chez un sujet humain à l'aide de biomarqueurs précoces |
BR112019022476A2 (pt) * | 2017-04-28 | 2020-05-12 | Abbott Laboratories | Métodos para o auxílio no diagnóstico e determinação hiperagudos de lesão cerebral traumática usando biomarcadores iniciais em pelo menos duas amostras a partir do mesmo ser humano |
BR112019025313A2 (pt) * | 2017-05-30 | 2020-06-23 | Abbott Laboratories | Métodos para auxílio no diagnóstico e avaliação de uma lesão cerebral traumática leve em um indivíduo humano usando troponina cardíaca i |
US11016105B2 (en) * | 2017-12-09 | 2021-05-25 | Abbott Laboratories | Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1 |
EP3721233A2 (fr) * | 2017-12-09 | 2020-10-14 | Abbott Laboratories | Procédés d'aide au diagnostic et à l'évaluation d'un sujet qui a subi une lésion orthopédique et qui a subi ou peut avoir subi une lésion à la tête, telle qu'une lésion cérébrale traumatique légère (tbi), à l'aide d'une protéine acide fibrillaire gliale (gfap) et/ou d'hydrolase carboxy-terminale d'ubiquitine l1 (uch-l1) |
-
2009
- 2009-08-11 EP EP23168587.6A patent/EP4235181A3/fr active Pending
- 2009-08-11 ES ES09807153.3T patent/ES2665245T3/es active Active
- 2009-08-11 AU AU2009282117A patent/AU2009282117B2/en active Active
- 2009-08-11 DK DK09807153.3T patent/DK2324360T3/en active
- 2009-08-11 NO NO09807153A patent/NO2324360T3/no unknown
- 2009-08-11 EP EP09807153.3A patent/EP2324360B1/fr not_active Revoked
- 2009-08-11 WO PCT/US2009/053376 patent/WO2010019553A2/fr active Application Filing
- 2009-08-11 CA CA2733990A patent/CA2733990C/fr active Active
- 2009-08-11 EP EP18154197.0A patent/EP3336551B1/fr active Active
- 2009-08-11 US US13/058,748 patent/US20110143375A1/en not_active Abandoned
- 2009-08-11 JP JP2011523089A patent/JP5781436B2/ja active Active
-
2014
- 2014-07-24 JP JP2014150903A patent/JP5976732B2/ja active Active
-
2017
- 2017-09-19 US US15/709,368 patent/US20180031577A1/en not_active Abandoned
-
2020
- 2020-06-02 US US16/890,943 patent/US20210011028A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2665245T3 (es) | 2018-04-25 |
AU2009282117B2 (en) | 2016-05-12 |
US20210011028A1 (en) | 2021-01-14 |
EP2324360A2 (fr) | 2011-05-25 |
EP2324360A4 (fr) | 2012-08-29 |
US20180031577A1 (en) | 2018-02-01 |
WO2010019553A2 (fr) | 2010-02-18 |
JP2014199262A (ja) | 2014-10-23 |
EP4235181A2 (fr) | 2023-08-30 |
US20110143375A1 (en) | 2011-06-16 |
DK2324360T3 (en) | 2018-05-14 |
AU2009282117A1 (en) | 2010-02-18 |
EP2324360B1 (fr) | 2018-01-31 |
JP5976732B2 (ja) | 2016-08-24 |
JP5781436B2 (ja) | 2015-09-24 |
CA2733990C (fr) | 2018-12-11 |
WO2010019553A3 (fr) | 2010-07-08 |
EP3336551B1 (fr) | 2023-05-31 |
EP4235181A3 (fr) | 2024-02-28 |
CA2733990A1 (fr) | 2010-02-18 |
EP3336551A1 (fr) | 2018-06-20 |
JP2012500388A (ja) | 2012-01-05 |